Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
J Neurol Neurosurg Psychiatry ; 87(8): 885-9, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26917698

RESUMO

BACKGROUND: Natalizumab (NTZ), a monoclonal antibody to human α4ß1/ß7 integrin, is an effective therapy for multiple sclerosis (MS), albeit associated with progressive multifocal leukoencephalopathy (PML). Clinicians have been extending the dose of infusions with a hypothesis of reducing PML risk. The aim of the study is to evaluate the clinical consequences of reducing NTZ frequency of infusion up to 8 weeks 5 days. METHODS: A retrospective chart review in 9 MS centres was performed in order to identify patients treated with extended interval dosing (EID) regimens of NTZ. Patients were stratified into 3 groups based on EID NTZ treatment schedule in individual centres: early extended dosing (EED; n=249) every 4 weeks 3 days to 6 weeks 6 days; late extended dosing (LED; n=274) every 7 weeks to 8 weeks 5 days; variable extended dosing (n=382) alternating between EED and LED. These groups were compared with patients on standard interval dosing (SID; n=1093) every 4 weeks. RESULTS: 17% of patients on SID had new T2 lesions compared with 14% in EID (p=0.02); 7% of patients had enhancing T1 lesions in SID compared with 9% in EID (p=0.08); annualised relapse rate was 0.14 in the SID group, and 0.09 in the EID group. No evidence of clinical or radiographic disease activity was observed in 62% of SID and 61% of EID patients (p=0.83). No cases of PML were observed in EID group compared with 4 cases in SID cohort. CONCLUSIONS: Dosing intervals up to 8 weeks 5 days did not diminish effectiveness of NTZ therapy. Further monitoring is ongoing to evaluate if the risk of PML is reduced in patients on EID.


Assuntos
Leucoencefalopatia Multifocal Progressiva/induzido quimicamente , Leucoencefalopatia Multifocal Progressiva/prevenção & controle , Esclerose Múltipla/tratamento farmacológico , Natalizumab/administração & dosagem , Natalizumab/uso terapêutico , Adulto , Esquema de Medicação , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Natalizumab/efeitos adversos , Neuroimagem , Recidiva , Estudos Retrospectivos
2.
AIDS ; 6(8): 837-41, 1992 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1418781

RESUMO

OBJECTIVE: To describe the clinical and pathologic features of two HIV-1-infected children with progressive multifocal leukoencephalopathy (PML). DESIGN: Case report. SETTING: University-affiliated, public-health trust hospital. METHODS: Two HIV-1-infected children with PML are described. A 13-year-old girl, presumed to be congenitally infected with HIV-1, presented with dysarthria and paresthesias of the tongue and chin that evolved rapidly to dementia, muteness and severe spastic quadriparesis. The other patient, a 10-year-old boy who developed HIV-1 infection from a blood transfusion at the age of 3 years, presented with a facial palsy with subsequent development of right hemiparesis and aphasia. RESULTS: Brain biopsy in the first child and autopsy in the second confirmed the diagnosis of PML. In both patients, the CD4 T-lymphocyte count was less than 100 x 10(6)l at the time of neurological presentation. CONCLUSION: Despite seroepidemiological studies suggesting that the majority of individuals are infected with JC virus during childhood, PML is rare in children with impaired cell-mediated immunity. Our patients illustrate that PML is among the neurological complications of HIV-1 infection in children.


Assuntos
Encéfalo/patologia , Infecções por HIV/complicações , HIV-1 , Leucoencefalopatia Multifocal Progressiva/patologia , Adolescente , Criança , Feminino , Humanos , Leucoencefalopatia Multifocal Progressiva/microbiologia , Masculino
3.
Neurology ; 44(3 Pt 1): 481-7, 1994 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8145919

RESUMO

Early reports of pediatric HIV-1-associated neuropathology described the presence of viral particles in some astrocytes, implicating direct infection of the immature nervous system as a contributing factor to the observed neuropathology. Several recent reports suggest that in those astrocytes infected with HIV-1, the level of antigenic expression of the proviral genome is below the sensitivity limits of conventional histochemical techniques. Identification of these astrocytes would instead require the use of a highly sensitive radiolabeled DNA or RNA probe for in situ hybridization to detect the persistent viral nucleic acids. To test this hypothesis, we examined autopsy tissue from 12 infants and children with AIDS-associated encephalopathy for the presence of HIV-1-infected astrocytes using combined isotopic in situ hybridization for the detection of viral-specific nucleic acids and immunohistochemistry for the identification of astrocytes. We detected HIV-1 nucleic acids in astrocytes in subcortical white matter from four pediatric patients with moderate to extensive leukoencephalitis. While gp41 was detectable only on macrophages and multinucleated giant cells, HIV-1 Nef protein was present in cells morphologically identified as astrocytes in two of these patients, further suggesting that HIV-1 establishes a persistent rather than a productive infection in astrocytes. Subcortical astrocytes may therefore be an unrecognized reservoir for HIV-1 in the developing nervous system of some children with AIDS-associated leukoencephalitis.


Assuntos
Complexo AIDS Demência/microbiologia , Astrócitos/microbiologia , HIV-1 , Química Encefálica , Criança , Pré-Escolar , Proteína Glial Fibrilar Ácida/análise , Humanos , Imuno-Histoquímica , Hibridização In Situ , Lactente
4.
Neurology ; 48(4): 836-45, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9109865

RESUMO

OBJECTIVE: To evaluate progressive multifocal leukoencephalopathy (PML) lesions using proton magnetic resonance spectroscopy (1H MRS). DESIGN: CSF polymerase chain reaction (PCR) detection for JC viral (JCV) DNA; MRI and localized 1H MRS in the PML lesions, normal-appearing contralateral brain regions (CONTRA), and in matched brain regions of normal subjects. SETTING: University-affiliated medical center. PATIENTS OR PARTICIPANTS: 20 AIDS patients with clinical diagnosis of PML, 16 had tissue and/or CSF evidence of JCV infection; 20 age-matched normal subjects. MAIN OUTCOME MEASURES: Metabolites from 1H MRS: N-acetyl aspartate (NA), creatine (CR), choline-containing compounds (CHO), myoinositol (MI), glutamine/glutamate (GLX), lactate, and lipids. RESULTS: CSF PCR for JCV DNA showed 86% sensitivity. MRI showed characteristic demyelinating lesions; commonest locations were frontal lobe and cerebellum. 1H MRS in the lesions showed decreased NA (-35%; p < 0.0001) and CR (-18%; p = 0.003), increased CHO (+28%; p = 0.0005), occasional increased MI, and excess lactate (15/20 lesions) and lipids (18/20). In the CONTRA, MRS showed trends for increased CR (+15%), CHO (+15%), MI (+13%), and lower GLX (-9%; p = 0.02). Six patients, studied longitudinally (4-18 months), showed progressive spectroscopic changes; two patients with longest survival showed the highest MI. CONCLUSIONS: These MRS findings are consistent with neuropathologic observations of neuronal loss, cell membrane and myelin breakdown, and increased glial activity in PML lesions. The CONTRA abnormalities may be due to remote effects of PML or direct HIV-1 infection. 1H MRS may be useful for characterization and follow-up evaluation of PML lesions.


Assuntos
Leucoencefalopatia Multifocal Progressiva/diagnóstico , Leucoencefalopatia Multifocal Progressiva/metabolismo , Espectroscopia de Ressonância Magnética , Adulto , Encéfalo/metabolismo , Encéfalo/patologia , Líquido Cefalorraquidiano/virologia , Genoma Viral , Humanos , Vírus JC/genética , Leucoencefalopatia Multifocal Progressiva/líquido cefalorraquidiano , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Prótons
5.
Neuroscience ; 85(2): 405-13, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9622240

RESUMO

The potential of a novel therapeutic approach for treating Parkinson's disease, which involves the transplantation of a transfected human astrocyte cell line SVG-TH, that stably expresses the rate-limiting enzyme for dopamine production, tyrosine hydroxylase, was examined. SVG-TH and untransfected parent cells were grafted into the diseased striatum of rats in which Parkinson's disease had been induced by the administration of 6-hydroxydopamine. The in situ production and spillover of 3,4-dihydroxyphenylalanine (the precursor of dopamine), dopamine and their metabolites in the striatal extracellular fluid of the grafted rats was determined in conscious animals using the microdialysis technique and a high pressure liquid chromatography apparatus. Alleviation of symptoms of Parkinson's disease (abnormal movements) was evaluated by rotation tests. Upon transplantation of the SVG-TH cells into the striatum of the parkinsonian rats, the levels of dopamine in extracellular fluid of the striatum reached those of the normal rats, and correlated well with the improvement (74%) in their rotating behaviour (behavioural deficit). The levels of the two main dopamine metabolites, dihydroxyphenylacetic acid and homovanillic acid, were low in the lesioned rats, even after SVG-TH transplantation. An alternative route of metabolism of dopamine may occur in the transplanted striatum, since the dopamine metabolite, 3-O-methoxy-4-hydroxy-phenylethylamine, appeared, which indicates activity of catechol-O-methyl transferase. Upon blockade of L-aromatic-amino acid decarboxylase, 3,4-dihydroxyphenylalanine accumulated in extracellular fluid of the 6-hydroxydopamine-lesioned and SVG-TH-grafted rats, which indicated that these cells produced active tyrosine hydroxylase in vivo. These findings indicate the potential of treating Parkinson's disease by the intrabrain grafting of human astrocyte cells transfected with the rate limiting enzyme for dopamine production.


Assuntos
Astrócitos/transplante , Corpo Estriado/metabolismo , Dopamina/metabolismo , Doença de Parkinson Secundária/genética , Doença de Parkinson Secundária/terapia , Transplantes , Animais , Astrócitos/metabolismo , Linhagem Celular , Corpo Estriado/citologia , Dopamina/biossíntese , Terapia Genética , Humanos , Levodopa/biossíntese , Levodopa/metabolismo , Masculino , Microdiálise , Ratos , Ratos Sprague-Dawley , Transfecção , Transgenes , Tirosina 3-Mono-Oxigenase/genética
6.
Biotechniques ; 20(4): 641-50, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8800684

RESUMO

The use of monoclonal antibodies to identify antigens in perfused fixed tissue is currently very challenging. Recently, many antigen retrieval methods have been described that require heating the tissue on slides using a microwave oven. Here, we describe a protocol for antigen retrieval that uses a commercially available solution called Citra and a DNA thermal cycler to heat the tissue sections. This method (i) allows for precise control of the temperature and time (unlike the microwave oven), (ii) uses very small quantities of the antigen retrieval solution, (iii) stains either free-floating sections or sections mounted on slides and (iv) achieves uniform staining throughout the tissue. In the paraformaldehyde-perfused fixed rat cerebellum, the monoclonal antibody glial fibrillary acidic protein conveys the clarity of the Bergmann and stellate glia in the strata. Scanning confocal images through the center of the tissue demonstrates the depth of antibody penetration achieved using this method. Finally, using a monoclonal antibody against the simian virus 40 (SV40) T antigen allowed positive, unequivocal identification of a grafted cell line, immortalized using SV40 T protein, thus demonstrating the true value of this method in an experimental paradigm.


Assuntos
Antígenos/análise , Imuno-Histoquímica/métodos , Reação em Cadeia da Polimerase/instrumentação , Fixação de Tecidos , Aldeídos , Animais , Anticorpos Monoclonais , Antígenos/imunologia , Antígenos Transformantes de Poliomavirus/análise , Linhagem Celular/transplante , Cerebelo , Proteína Glial Fibrilar Ácida/análise , Masculino , Microscopia Confocal , Microtomia , Micro-Ondas , Ratos , Ratos Sprague-Dawley , Coloração e Rotulagem/métodos , Temperatura
7.
AIDS Res Hum Retroviruses ; 10(10): 1207-11, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7848678

RESUMO

In vitro, HIV-1 infection of human fetal glial cells initiates a noncytopathic, productive infection that results in a long-term persistence during which the viral genome remains latent. The cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) reactivate HIV-1 gene expression in these cells, leading to production of infectious virus. Here we show that treatment of human fetal glial cells with TNF-alpha and IL-1 beta increase expression of the reporter gene chloramphenicol acetyltransferase (CAT) when placed under the control of the HIV-1 5' LTR. We also show that treatment of human fetal glial cells with TNF-alpha leads to increased binding of the nuclear transcription factor NF-kappa B (p50/p65) to a consensus kappa B-binding site present in the HIV-1 5'LTR. Our results suggest that TNF-alpha stimulation of HIV-1 gene expression in primary cultures of human fetal glial cells is mediated by an increase in binding of NF-kappa B (p50/p65) to the HIV-1 LTR. This is the first report documenting NF-kappa B-binding activity in primary cultures of human fetal glial cells.


Assuntos
Expressão Gênica/efeitos dos fármacos , HIV-1/fisiologia , NF-kappa B/biossíntese , Neuroglia/metabolismo , Fator de Necrose Tumoral alfa/farmacologia , Sequência de Bases , Sítios de Ligação , Encéfalo/metabolismo , Núcleo Celular/metabolismo , Citocinas/farmacologia , Feto , Genoma Viral , Repetição Terminal Longa de HIV , HIV-1/efeitos dos fármacos , HIV-1/genética , Humanos , Dados de Sequência Molecular , NF-kappa B/metabolismo , Subunidade p50 de NF-kappa B , Neuroglia/efeitos dos fármacos , Neuroglia/virologia , Sondas de Oligonucleotídeos , Fator de Transcrição RelA , Transfecção , Latência Viral
8.
Brain Res Mol Brain Res ; 56(1-2): 273-6, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-9602149

RESUMO

Nerve growth factor (NGF) acts as an anti-mitogenic factor in C6-2B glioma cells stably expressing TrkA (C6trk+). To study the effect of TrkA on cell growth in vivo, we grafted mock and C6trk+ cells into the striatum of ACI nude rats. Thy 1.1 and p75NTR immunohistochemistry revealed that wild type C6-2B cells formed a tumor mass in the striatum by 14 days. In contrast, C6trk+ transplanted rats did not show the presence of a significant tumor mass until 71 days. Analysis of this tumor showed that expression of TrkA was retained, but the synthesis of NGF was abolished. Our data encourage the speculation that expression of TrkA in glioblastoma in vivo will attenuate tumor progression.


Assuntos
Corpo Estriado/metabolismo , Corpo Estriado/patologia , Glioma/metabolismo , Proteínas Proto-Oncogênicas/fisiologia , Receptores Proteína Tirosina Quinases/fisiologia , Receptores de Fator de Crescimento Neural/fisiologia , Animais , Divisão Celular/genética , Glioma/patologia , Imuno-Histoquímica , Proteínas Proto-Oncogênicas/genética , Ratos , Ratos Nus , Receptores Proteína Tirosina Quinases/genética , Receptor trkA , Receptores de Fator de Crescimento Neural/genética , Transfecção , Células Tumorais Cultivadas
9.
Cell Transplant ; 6(3): 317-26, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9171164

RESUMO

The C6-2B is a well-characterized glioma cell line used extensively in the study of malignant glial biology. While the C6-2B cell line has traditionally been thought of as a homogenous cell line, the in vitro phenotype of the C6-2B cell line can vary considerably depending on the culture technique used and the stratum on which the cells are grown. Thus, we asked whether the in vitro phenotype of the C6-2B cell line was significantly different than the in vivo phenotype of the cell line once it was engrafted into the striatum of nude rats. Under culture conditions used in our laboratory, 100% of the C6 cells were found to express p75, the low-affinity nerve growth factor (NGF) receptor, and Major Histocompatability Class I (MHC Class I), while only 10-15% demonstrated vimentin reactivity. Immunohistochemistry was consistently negative for GFAP, trkA (the high-affinity receptor for NGF), CD4, CD8, and a macrophage specific marker (Ox-41). Once engrafted into the striatum of nude rats, the cells remained 100% p75 and MHC Class I positive, and again, only 15% of the cells demonstrated vimentin reactivity. The grafted cells retained this characteristic for 28 days in vivo. Although an immunoincompetent host was selected to minimize the effects an inflammatory response would have on the graft, a transient inflammatory response was detected. During the first week of engraftment, numerous MHC class II cells, some of which were macrophages, were seen infiltrating the graft. However, by 4 weeks postengraftment, no inflammatory cells were appreciated in the graft and surprisingly little reactive gliosis was seen in the penumbra of the tumor mass. Thus, the limited number of in vitro phenotypic characteristics we examined in the C6-2B cell line remained constant once the cells were engrafted into the striatum of athymic nude rats.


Assuntos
Glioma , Células Tumorais Cultivadas/transplante , Animais , Corpo Estriado/patologia , Corpo Estriado/cirurgia , Proteína Glial Fibrilar Ácida/análise , Proteína Glial Fibrilar Ácida/genética , Gliose/fisiopatologia , Técnicas Imunoenzimáticas , Masculino , Fenótipo , Ratos , Ratos Endogâmicos ACI , Ratos Nus , Células Tumorais Cultivadas/química , Vimentina/análise , Vimentina/genética
10.
Cell Transplant ; 6(3): 231-8, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9171156

RESUMO

In vitro growth properties of three CNS-derived cell lines were compared under a variety of culture conditions. The M213-20 and J30a cell lines were each derived from embryonic CNS culture with the temperature-sensitive (ts) allele of SV40 large T antigen, tsA58, while the A7 cell line was immortalized using wild-type SV40 large T antigen. Cells immortalized with tsA58 SV40 large T proliferate at the permissive temperature, 33 degrees C, while growth is expected to be suppressed at the nonpermissive temperature, 39.5 degrees C. Both the M213-20 and J30a cell lines were capable of proliferating at 39.5 degrees C continuously for up to 6 mo. All three cell lines showed no appreciable differences in growth rates related to temperature over a 7-day period in either serum-containing or defined serum-free media. The percentage of cells in S-phase of the cell cycle did not decrease or was elevated at 39.5 degrees C for all three cell lines. After 3 wk at 39.5 degrees C, the three cell lines also showed positive immunostaining using two monoclonal antibodies reacting with different epitopes of SV40 large T antigen. Double strand DNA sequence analyses of a 300 base pair (bp) fragment of the large T gene from each cell line, which included the ts locus, revealed mutations in both the J30a and M213-20 cell lines. The J30a cell line ts mutation had reverted to wild type, and two additional loci with bp substitutions with predicted amino acid changes were also found. While the ts mutation of the M213-20 cells was retained, an additional bp substitution with a predicted amino acid change was found. The A7 cell line sequence was identical to the reference wild-type sequence. These findings suggest that (a) nucleic acid sequences in the temperature-sensitive region of the tsA58 allele of SV40 large T are not necessarily stable, and (b) temperature sensitivity of cell lines immortalized with tsA58 is not necessarily retained.


Assuntos
Antígenos Transformantes de Poliomavirus/genética , Corpo Estriado/citologia , Neurônios/citologia , Alelos , Animais , Antígenos Transformantes de Poliomavirus/análise , Sequência de Bases , Proteínas Sanguíneas/farmacologia , Ciclo Celular/fisiologia , Divisão Celular/fisiologia , Linhagem Celular Transformada/química , Linhagem Celular Transformada/citologia , Linhagem Celular Transformada/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Meios de Cultura Livres de Soro/farmacologia , Feto/citologia , Citometria de Fluxo , Imuno-Histoquímica , Dados de Sequência Molecular , Neurônios/química , Neurônios/efeitos dos fármacos , Mutação Puntual , Ratos , Fase S/fisiologia , Análise de Sequência de DNA , Temperatura
11.
Cell Transplant ; 5(2): 145-63, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8689028

RESUMO

The use of primary human fetal tissue in the treatment of neurodegenerative disorders, while promising, faces several difficult technical and ethical issues. An alternative approach that would obviate these problems would be to use immortalized cell lines of human fetal central nervous system origin. An immortalized human fetal astrocyte cell line (SVG) has been established (45) and herein we describe the in vitro and in vivo characteristics of this cell line which suggest that it may be a useful vehicle for neural transplantation. The SVG cell line is vimentin, GFAP, Thy 1.1 and MHC class I positive, and negative for neurofilament and neuron specific enolase, consistent with its glial origin. To determine whether the cell line could be used as a drug delivery system, a cDNA expression vector for tyrosine hydroxylase was constructed (phTH/Neo) and stably expressed in the SVG cells for over 18 months as demonstrated by immunohistochemistry and Western blotting of the stable transfectants. HPLC analysis of the supernatant from these cells, termed SVG-TH, consistently found 4-6 pmol/ml/min of l-dopa produced with the addition of BH4 to the media. Furthermore, in cocultivation experiments with hNT neurons, PC-12 cells and primary rat fetal mesencephalic tissue, both the SVG and SVG-TH cells demonstrated neurotrophic potential, suggesting that they constituitively express factors with neuroregenerative potential. To determine the viability of these cells in vivo, SVG-TH cells were grafted into the striatum of Sprague-Dawley rats and followed over time. A panel of antibodies was used to unequivocally differentiate the engrafted cells from the host parenchyma, including antibodies to: SV40 large T antigen (expressed in the SVG-TH cells), human and rat MHC class 1, vimentin, GFAP, and tyrosine hydroxylase. While the graft was easily identified with the first week, over the course of a four week period of time the engrafted cells decreased in number. Concomittantly, rat CD4 and CD8 expression in the vicinity of the graft increased, consistent with xenograft rejection. When the SVG-TH cells were grafted to the lesioned striatum of a 6-hydroxydopamine lesioned rats, rotational behavior of the rat decreased as much as 80% initially, then slowly returned to baseline over the next four weeks, parallelling graft rejection. Thus, the SVG-TH cells can induce a functional recovery in an animal model of Parkinson's disease, however as a xenograft, the SVG cells are recognized by the immune system.


Assuntos
Astrócitos/transplante , Transplante de Tecido Fetal , Tirosina 3-Mono-Oxigenase/metabolismo , Animais , Astrócitos/enzimologia , Astrócitos/ultraestrutura , Divisão Celular/fisiologia , Linhagem Celular/citologia , Linhagem Celular/enzimologia , Linhagem Celular/ultraestrutura , Tamanho Celular/fisiologia , Sobrevivência Celular/fisiologia , Modelos Animais de Doenças , Feto/citologia , Feto/enzimologia , Citometria de Fluxo , Regulação Enzimológica da Expressão Gênica/fisiologia , Engenharia Genética , Humanos , Imuno-Histoquímica , Masculino , Microscopia Eletrônica , Neostriado , Neuritos/fisiologia , Oxidopamina/farmacologia , Células PC12/citologia , Doença de Parkinson Secundária/terapia , Plasmídeos , Ratos , Ratos Sprague-Dawley , Fatores de Tempo , Transplante Heterotópico , Tirosina 3-Mono-Oxigenase/genética
12.
Brain Res ; 799(2): 250-6, 1998 Jul 20.
Artigo em Inglês | MEDLINE | ID: mdl-9675302

RESUMO

Niemann-Pick disease Type C (NPC) is a progressive neurovisceral metabolic disorder that is caused in most patients by a defect in a recently found gene, NPC-1. Neurological damage includes visual disorders such as vertical supranuclear gaze palsy, movement disorders such as dystonia and ataxia, dementia, and seizures. So far the biochemical deficit, most likely manifested by delayed intracellular cholesterol transport, has not been correlated with the progressive neurological damage. A mutant Balb/C mouse with a defect in the same gene is used as a model to study NPC. Pathological examination of brain tissue obtained by autopsy from NPC patients or brains of affected NPC mice of different ages, revealed signs of extensive damage throughout the brain, including neurofibrillary tangles and intracellular storage of various compounds. Loss of cerebellar Purkinje cells was the most significant specific damage. The present study examined whether the neurochemical changes present in the NPC mouse brain were related to the pathological changes. The results show major alterations in the levels of serotonin and its main metabolite, 5-hydroxyindoleacetic acid, in the cerebellum and cortex of NPC mice. The levels of the inhibitory amino acid glycine were threefold higher in the cerebellum of NPC mice and those of glutamate and GABA decreased in the cortex. Tyrosine hydroxylase immunoreactivity was present in Purkinje cells, and the levels of L-DOPA increased specifically in the vermis of the cerebellum. These results are the first to indicate changes in neurotransmitters in NPC and that these could be correlated with some of the neuropathology of this disease.


Assuntos
Cerebelo/metabolismo , Doenças de Niemann-Pick/metabolismo , Aminoácidos/metabolismo , Animais , Monoaminas Biogênicas/metabolismo , Encéfalo/metabolismo , Encéfalo/patologia , Cerebelo/patologia , Feminino , Imuno-Histoquímica , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Neurotransmissores/metabolismo , Doenças de Niemann-Pick/patologia , Valores de Referência , Distribuição Tecidual , Tirosina 3-Mono-Oxigenase/metabolismo
13.
AJNR Am J Neuroradiol ; 21(7): 1251-4, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10954277

RESUMO

Diplopia, nystagmus, visual hallucinations, and internuclear ophthalmoplegia developed in a 30-year-old woman 84 days after she received a matched, unrelated bone marrow transplant for chronic myeloid leukemia. A regimen of tacrolimus had been administered since the transplantation was performed. MR imaging revealed bilaterally symmetric regions of signal abnormality with abnormal contrast enhancement in the brain stem. No supratentorial abnormality was present. Tacrolimus therapy was discontinued, and the symptoms resolved. MR imaging that was performed 10 days after tacrolimus was discontinued showed resolution of the abnormalities.


Assuntos
Transplante de Medula Óssea , Tronco Encefálico/efeitos dos fármacos , Imunossupressores/efeitos adversos , Leucemia Mielogênica Crônica BCR-ABL Positiva/terapia , Imageamento por Ressonância Magnética , Síndromes Neurotóxicas/etiologia , Tacrolimo/efeitos adversos , Adulto , Tronco Encefálico/patologia , Feminino , Seguimentos , Humanos , Imunossupressores/uso terapêutico , Síndromes Neurotóxicas/diagnóstico , Remissão Espontânea , Tacrolimo/uso terapêutico
16.
J Am Optom Assoc ; 62(8): 634-9, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1813574

RESUMO

A frequent occurrence in geriatric and chronically ill patients is the exhibition of several simultaneously occurring and confounding health problems. This paper reports the case of a 61-year-old-white male who presented with an extensive history of multiple brain infarcts, hemiparesis, personality changes and varied visual complaints. Tests in the neurooptometric work-up for this patient included static automated perimetry, stereoacuity and optokinetic nystagmus evaluation. The results were suggestive of multiple cerebrovascular accidents which included the right and left occipital lobes as well as the right parietal lobe. This clinical picture was complicated by the presence of nutritional or ethanol-induced optic neuropathy. Emphasis was placed on a detailed sequential history of events and a complete neurological and optometric evaluation to ascertain the multiple foci of cortical infarction. Corroboration of clinical findings was obtained by computerized axial tomography (CT scan).


Assuntos
Alcoolismo/complicações , Infarto Cerebral/diagnóstico , Lobo Occipital , Doenças do Nervo Óptico/diagnóstico , Lobo Parietal , Etanol/efeitos adversos , Fundo de Olho , Hemianopsia/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade , Nistagmo Fisiológico , Lobo Occipital/diagnóstico por imagem , Doenças do Nervo Óptico/etiologia , Lobo Parietal/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Campos Visuais
17.
J Virol ; 65(11): 6094-100, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1920627

RESUMO

Human immunodeficiency virus type 1 (HIV-1) infection of the brain has been associated with a severe dementing illness in children and adults. However, HIV-1 antigens are most frequently found in macrophages and microglial cells. To determine the extent of susceptibility of neuroglial cells to infection, the HIV-1 genome was introduced into cells cultured from human fetal brain tissue. Astroglial cells rapidly transcribed the viral genome producing high levels of p24 protein and infectious virions which peaked two to three days posttransfection. Thereafter HIV-1 genome expression progressively diminished and a persistent phase of infection developed during which neither virus nor viral proteins could be demonstrated by immunodetection methods. Cocultivation with CD4+ T cells at any time during the persistent infection resulted in resumption of p24 synthesis and virus multiplication. The release of persistence did not require direct cell-cell contact between the glial and T cells, since separation of the two cell types across a permeable membrane resulted in a delayed but similar resumption of p24 synthesis and virus multiplication. The persistently infected glial cells could also be stimulated to produce viral p24 protein if either tumor necrosis factor alpha or interleukin-1 beta was added to the medium without T cells present. These results suggest that astrocytes may serve as an undetected reservoir for HIV-1 and disseminate the virus to other susceptible cells in the brain upon triggering by some cellular or biochemical signal.


Assuntos
Encéfalo/citologia , HIV-1/fisiologia , Interleucina-1/farmacologia , Neuroglia/citologia , Fator de Necrose Tumoral alfa/farmacologia , Astrócitos/citologia , Encéfalo/embriologia , Células Cultivadas , Citocinas/farmacologia , Feto , Antígenos HIV/análise , HIV-1/efeitos dos fármacos , HIV-1/imunologia , Humanos , Neuroglia/efeitos dos fármacos , Plasmídeos , Proteínas Recombinantes/farmacologia , Transfecção
18.
Clin Microbiol Rev ; 5(1): 49-73, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1310438

RESUMO

Studies of the pathogenesis and molecular biology of JC virus infection over the last two decades have significantly changed our understanding of progressive multifocal leukoencephalopathy, which can be described as a subacute viral infection of neuroglial cells that probably follows reactivation of latent infection rather than being the consequence of prolonged JC virus replication in the brain. There is now sufficient evidence to suggest that JC virus latency occurs in kidney and B cells. However, JC virus isolates from brain or kidney differ in the regulatory regions of their viral genomes which are controlled by host cell factors for viral gene expression and replication. DNA sequences of noncoding regions of the viral genome display a certain heterogeneity among isolates from brain and kidney. These data suggest that an archetypal strain of JC virus exists whose sequence is altered during replication in different cell types. The JC virus regulatory region likely plays a significant role in establishing viral latency and must be acted upon for reactivation of the virus. A developing hypothesis is that reactivation takes place from latently infected B lymphocytes that are activated as a result of immune suppression. JC virus enters the brain in the activated B cell. Evidence for this mechanism is the detection of JC virus DNA in peripheral blood lymphocytes and infected B cells in the brains of patients with progressive multifocal leukoencephalopathy. Once virus enters the brain, astrocytes as well as oligodendrocytes support JC virus multiplication. Therefore, JC virus infection of neuroglial cells may impair other neuroglial functions besides the production and maintenance of myelin. Consequently our increased understanding of the pathogenesis of progressive multifocal leukoencephalopathy suggests new ways to intervene in JC virus infection with immunomodulation therapies. Perhaps along with trials of nucleoside analogs or interferon administration, this fatal disease, for which no consensus of antiviral therapy exists, may yield to innovative treatment protocols.


Assuntos
Encefalopatias/etiologia , Doenças Desmielinizantes/etiologia , Vírus JC/genética , Infecções Tumorais por Vírus , Animais , Sequência de Bases , Encéfalo/microbiologia , Encefalopatias/tratamento farmacológico , Neoplasias Encefálicas/etiologia , Linhagem Celular , Cricetinae , Doenças Desmielinizantes/tratamento farmacológico , Genes Virais , Humanos , Vírus JC/isolamento & purificação , Vírus JC/patogenicidade , Camundongos , Dados de Sequência Molecular
19.
J Virol ; 68(1): 93-102, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8254781

RESUMO

Human immunodeficiency virus type 1 (HIV-1) infection of the developing central nervous system results in a dementing process in children, termed HIV-1-associated encephalopathy. Infection of astroglial elements of the pediatric nervous system has been demonstrated and suggests that direct infection of some astrocytes may contribute to the neurologic deficit. In this model, HIV-1 establishes a persistent state of infection in astrocytes, which can be reactivated by the cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta). To better understand the natural history of viral persistence in astroglial cells, we characterized infection at the transcriptional level. The most abundant viral transcript during the establishment of persistence was the subgenomic multiply spliced 2-kb message, similar to mononuclear cell models of HIV-1 latency. Following reactivation with TNF-alpha or IL-1 beta the multiply spliced 2-kb message remained the most abundant viral transcript, in contrast to infected mononuclear cells in which reactivation leads to the reemergence of the 9- and 4-kb transcripts. Further characterization of the persistent 2-kb transcript by PCR amplification of in vitro-synthesized viral cDNA showed that, in the absence of cytokine stimulation, the most abundant multiply spliced transcripts were the Nef- and Rev-specific messages. However, following cytokine stimulation, double- and triple-spliced Tat-, Rev-, and Nef-specific messages could be identified. Immunohistochemical staining demonstrated that, during viral persistence, astrocytes expressed Nef protein but few or no viral structural proteins. These results demonstrate that viral persistence in astrocytes at the transcriptional level is fundamentally different from that seen in mononuclear cells and could account for the virtual absence of astroglial expression of viral structural antigens in vivo.


Assuntos
Astrócitos/microbiologia , HIV-1/crescimento & desenvolvimento , RNA Mensageiro/metabolismo , RNA Viral/metabolismo , Transcrição Gênica , Astrócitos/citologia , Sequência de Bases , Encéfalo/citologia , Encéfalo/microbiologia , Feto , Produtos do Gene nef/genética , Produtos do Gene nef/metabolismo , Produtos do Gene rev/genética , Produtos do Gene rev/metabolismo , Produtos do Gene tat/genética , Produtos do Gene tat/metabolismo , Proteína do Núcleo p24 do HIV/genética , Proteína do Núcleo p24 do HIV/metabolismo , Proteína gp41 do Envelope de HIV/genética , Proteína gp41 do Envelope de HIV/metabolismo , HIV-1/genética , Humanos , Imuno-Histoquímica , Interleucina-1/farmacologia , Dados de Sequência Molecular , Splicing de RNA , Fatores de Tempo , Fator de Necrose Tumoral alfa/farmacologia , Replicação Viral , Produtos do Gene nef do Vírus da Imunodeficiência Humana , Produtos do Gene rev do Vírus da Imunodeficiência Humana , Produtos do Gene tat do Vírus da Imunodeficiência Humana
20.
J Neurosci Res ; 64(6): 636-45, 2001 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-11398188

RESUMO

Nerve growth factor (NGF) binds to the TrkA tyrosine kinase and the p75 neurotrophin receptors. Depending upon which receptor is activated, NGF can induce differentiation or apoptosis. C6-2B glioma cells express the p75 receptor, but NGF decreases their growth only when TrkA is introduced (C6trk). It is unclear, however, whether TrkA reduces C6-2B cell growth by apoptosis or differentiation. To examine which mechanisms account for the anti-proliferative effect of NGF in these cells, we first analyzed whether NGF causes apoptosis by flow cytometry, two-site immunoassay and in situ TUNEL. None of these methods indicated that C6trk undergo apoptosis. Additional apoptotic markers, such as Bcl-2, Bax, Bad, p53, caspase 3, and NF-kappaB were also used. C6trk cells exhibited lower levels of Bcl-2 compared with the parental C6 mock cells, but no changes in the levels of other apoptotic proteins. Moreover, NGF increased AP-1 binding activity in C6trk cells, suggesting that NGF may induce differentiation. We then examined whether TrkA changes the glioma phenotype. In C6trk cells, but not in C6mock cells, NGF enhanced the levels of neuron-specific enolase as well as the levels of A2B5 and 2', 3'-cyclic nucleotide 3'-phosphodiesterase, markers for oligodendrocytes, without affecting the expression of other neuronal markers. Our data suggest that the antiproliferative properties of TrkA may rely on its ability to induce differentiation of C6 cells from undifferentiated glioma to oligodendrocytes.


Assuntos
Glioma , Oligodendroglia/citologia , Receptor trkA/metabolismo , Animais , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Marcação In Situ das Extremidades Cortadas , NF-kappa B/análise , NF-kappa B/metabolismo , Fator de Crescimento Neural/farmacologia , Oligodendroglia/metabolismo , Fosforilação , Proteínas Proto-Oncogênicas/análise , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/análise , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Ratos , Receptor de Fator de Crescimento Neural/análise , Receptor de Fator de Crescimento Neural/metabolismo , Fator de Transcrição AP-1/metabolismo , Células Tumorais Cultivadas/química , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/metabolismo , Proteína Supressora de Tumor p53/análise , Proteína X Associada a bcl-2
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa